The Food and Drug Administration’s approval of the abortion drug RU-486 sparked a new round of debate between pro-life and pro-choice activists, but it also brought forth a new discussion about the drug’s medical benefits and drawbacks, who will be allowed to administer it, and how states will regulate its use. A panel talks about the new concerns raised by the introduction of RU-486 in the U.S.

Guests

  • Richard Pierce professor of administrative law at George Washington University
  • Dr. Mitchell Creinin physician
  • Maxine Klane Planned Parenthood of Metropolitan Washington

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Readers Review: “The Legend of Sleepy Hollow” by Washington Irving

Wednesday, Oct 29 2014For our October Readers’ Review: a novella that became an instant classic when it was written nearly two centuries ago. It is the ghostly tale of a lanky loner and a headless horseman. Some even call it the first American horror story. Join Diane and her guests for a discussion of “The Legend of Sleepy Hollow” by Washington Irving.

Campaign Spending On State Judicial Elections

Wednesday, Oct 29 2014Campaign spending has reached new heights in some state judicial elections. Please join us to talk about the growing need to raise and spend money in judicial elections and how this spending may affect judicial integrity and public confidence.